Moderna to ask FDA for COVID-19 vaccine authorization

Moderna Therapeutics...
Photo by Blake Nissen for The Boston Globe via Getty Images

Moderna plans to file for authorization of its COVID-19 vaccine today, after the final analysis of its clinical trial data confirmed that it is safe and 94 percent effective. It is the second company to submit COVID-19 vaccine data to the Food and Drug Administration, after Pfizer and BioNTech submitted their data earlier this month.

In a press release, Moderna said that there were 196 cases of symptomatic COVID-19 reported in the 30,000-person trial. Of those cases, 185 developed in people who received a placebo, and 11 cases developed in people who took the vaccine. There were 30 cases of severe disease in the trial, and all of them were in the placebo group — indicating that the vaccine can prevent the most dangerous forms of…

Continue reading…

This post has been read 25 times!

0 0 vote
Article Rating
Like
Like Love Haha Wow Sad Angry
guest
Not Optional
Optional
0 Comments
Inline Feedbacks
View all comments